Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010.

Animals Anti-Inflammatory Agents Endocannabinoids Humans Ligands Patents as Topic Receptors, Cannabinoid Signal Transduction
G protein-coupled receptor agonist cannabinoid receptor type 1 cannabinoid receptor type 2 endocannabinoid system endocannabinoids

Journal

Pharmaceutical patent analyst
ISSN: 2046-8962
Titre abrégé: Pharm Pat Anal
Pays: England
ID NLM: 101582615

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 12 6 2021
medline: 29 10 2021
entrez: 11 6 2021
Statut: ppublish

Résumé

The G-protein-coupled cannabinoid receptor type 2 (CB

Identifiants

DOI: 10.4155/ppa-2021-0002 PMID: 34111979
pubmed: 34111979
doi: 10.4155/ppa-2021-0002
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Endocannabinoids 0
Ligands 0
Receptors, Cannabinoid 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-163

Auteurs

Benjamin Brennecke (B)

Medicinal Chemistry, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Berlin, Berlin, 13125, Germany.

Thais Gazzi (T)

Medicinal Chemistry, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Berlin, Berlin, 13125, Germany.

Kenneth Atz (K)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.
ORCID: 0000-0002-2628-1619

Jürgen Fingerle (J)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.

Pascal Kuner (P)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.
ORCID: 0000-0001-6513-5414

Torsten Schindler (T)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.

Guy de Weck (G)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.

Marc Nazaré (M)

Medicinal Chemistry, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) Berlin, Berlin, 13125, Germany.
ORCID: 0000-0002-1602-2330

Uwe Grether (U)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.
ORCID: 0000-0002-3164-9270

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Cannabinoid receptor type 2 ligands: an...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-inflammatoires › Cannabinoid receptor type 2 ligands: an...
questionsmedicales.fr › Lipides › Acides gras › Endocannabinoïdes › Cannabinoid receptor type 2 ligands: an...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cannabinoid receptor type 2 ligands: an...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Ligands › Cannabinoid receptor type 2 ligands: an...
questionsmedicales.fr › Organisations et économie des soins de santé › Contrôle social formel › Jurisprudence › Propriété intellectuelle › Brevets comme sujet › Cannabinoid receptor type 2 ligands: an...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs couplés aux protéines G › Récepteurs de cannabinoïdes › Cannabinoid receptor type 2 ligands: an...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Cannabinoid receptor type 2 ligands: an...